17.09.2013 Views

PDA Supply Chain Security in the Pharmaceutical Industry.pdf

PDA Supply Chain Security in the Pharmaceutical Industry.pdf

PDA Supply Chain Security in the Pharmaceutical Industry.pdf

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

t:<br />

e of<br />

al<br />

The <strong>PDA</strong> Sou<strong>the</strong>rn California Chapter is Proud to Present:<br />

The <strong>PDA</strong> Sou<strong>the</strong>rn “Insight California from Chapter <strong>the</strong> Experts” is Proud to Present:<br />

The <strong>PDA</strong> Sou<strong>the</strong>rn “Insight California from Chapter <strong>the</strong> Experts” is Proud to Present:<br />

“Insight Steven Wolfgang from <strong>the</strong> Experts”<br />

Steven Wolfgang<br />

Compliance)<br />

Steven Wolfgang<br />

Compliance)<br />

Kev<strong>in</strong> Siver<br />

Compliance)<br />

(Director of Supplier Kev<strong>in</strong> Quality Siver Management, Amgen )<br />

(Director of Supplier Quality Management, Amgen )<br />

Lucy<br />

Kev<strong>in</strong><br />

Medeiros<br />

Siver<br />

Cabral<br />

(Director of Supplier Quality Management, Amgen )<br />

(Head of Global Supplier Lucy Medeiros Quality Management, Cabral Genentech/Roche)<br />

(Head of Global Supplier Lucy Quality Management, Genentech/Roche)<br />

Gerard<br />

Medeiros<br />

Pearce<br />

Cabral<br />

(Head of Global Supplier Quality Management, Genentech/Roche)<br />

(Executive Gerard Vice President, Pearce SQA Services )<br />

(Executive Gerard Vice President, Pearce SQA Services )<br />

(FDA Act<strong>in</strong>g Associate Director, Office of Drug <strong>Security</strong>, Integrity and Recalls (ODSIR) Office of<br />

(FDA Act<strong>in</strong>g Associate Director, Office of Drug <strong>Security</strong>, Integrity and Recalls (ODSIR) Office of<br />

(FDA Act<strong>in</strong>g Associate Director, Office of Drug <strong>Security</strong>, Integrity and Recalls (ODSIR) Office of<br />

On <strong>the</strong> Subject of<br />

(Executive Vice President, SQA Services )<br />

On <strong>the</strong> Subject of<br />

On <strong>the</strong> Subject of<br />

“<strong>Supply</strong> <strong>Cha<strong>in</strong></strong> <strong>Security</strong> <strong>in</strong> <strong>the</strong> <strong>Pharmaceutical</strong><br />

<strong>Industry</strong>”<br />

August 30 th “<strong>Supply</strong> <strong>Cha<strong>in</strong></strong> <strong>Security</strong> <strong>in</strong> <strong>the</strong> <strong>Pharmaceutical</strong><br />

“<strong>Supply</strong> <strong>Cha<strong>in</strong></strong> <strong>Security</strong> <strong>in</strong> <strong>the</strong> <strong>Pharmaceutical</strong><br />

<strong>Industry</strong>”<br />

<strong>Industry</strong>”<br />

, 2011 (Tuesday Morn<strong>in</strong>g)<br />

August 30<br />

Registration/Network<strong>in</strong>g with<br />

Cont<strong>in</strong>ental Breakfast: 8:00-9:00AM<br />

Presentations: 9:00-Noon<br />

Three locations to choose from:<br />

Amgen<br />

Hilton Hotel Irv<strong>in</strong>e<br />

Genentech/Roche<br />

Conference Center<br />

Orange County Airport<br />

Facility<br />

th , 2011 (Tuesday Morn<strong>in</strong>g)<br />

August 30<br />

Registration/Network<strong>in</strong>g with<br />

Cont<strong>in</strong>ental Breakfast: 8:00-9:00AM<br />

Presentations: 9:00-Noon<br />

Three locations to choose from:<br />

Amgen<br />

Hilton Hotel Irv<strong>in</strong>e<br />

Genentech/Roche<br />

th , 2011 (Tuesday Morn<strong>in</strong>g)<br />

Registration/Network<strong>in</strong>g with<br />

The <strong>PDA</strong> Sou<strong>the</strong>rn California Chapter is Proud to Present:<br />

Cont<strong>in</strong>ental “Insight Breakfast: from <strong>the</strong> 8:00-9:00AM Experts”<br />

Presentations: 9:00-Noon<br />

Steven Wolfgang<br />

Three locations to choose from:<br />

(FDA Act<strong>in</strong>g Associate Director, Office of Drug <strong>Security</strong>, Integrity and Recalls (ODSIR) Office of<br />

Conference (Thousand Amgen Oaks) Center<br />

Orange Hilton (Orange Compliance)<br />

County Hotel County) Irv<strong>in</strong>e Airport<br />

Genentech/Roche<br />

(Oceanside) Facility<br />

Conference (Thousand Oaks) Center<br />

Orange (Orange County) Kev<strong>in</strong> County Siver Airport<br />

(Oceanside) Facility<br />

Webcast (Thousand / Live Oaks) Feed Available - Contact (Orange County) Bill Nichols (<strong>in</strong>fo on registration form)<br />

(Director of Supplier Quality Management, Amgen (Oceanside) )<br />

Webcast / Live Feed Available - Contact Bill Nichols (<strong>in</strong>fo on registration form)<br />

Webcast / Live Feed Available Lucy - Medeiros Contact Bill Nichols Cabral (<strong>in</strong>fo on registration form)<br />

(Head of Global Supplier Sponsored Quality Management, By: Genentech/Roche)<br />

Sponsored By:<br />

Gerard Sponsored Pearce By:<br />

(Executive Vice President, SQA Services )<br />

On <strong>the</strong> Subject of<br />

“<strong>Supply</strong> <strong>Cha<strong>in</strong></strong> <strong>Security</strong> <strong>in</strong> <strong>the</strong> <strong>Pharmaceutical</strong><br />

<strong>Industry</strong>”<br />

th


quality operation by connect<strong>in</strong>g a<br />

president and head of operations w<br />

r, and is closely <strong>in</strong>volved <strong>in</strong> shap<strong>in</strong>g<br />

ortune 500 clients .<br />

Information on Topic & Speakers:<br />

Presentation Overview:<br />

Exhibitors:<br />

Exhibitors:<br />

This chapter event will provide <strong>in</strong>sight to <strong>the</strong> current issues <strong>the</strong> pharmaceutical <strong>in</strong>dustry is fac<strong>in</strong>g <strong>in</strong><br />

secur<strong>in</strong>g its supply cha<strong>in</strong> and <strong>in</strong>forms you about <strong>the</strong> current and future challenges. Steven Wolfgang<br />

from FDA will open <strong>the</strong> session from Wash<strong>in</strong>gton DC by shar<strong>in</strong>g FDA’s latest th<strong>in</strong>k<strong>in</strong>g on this subject.<br />

The Information event will be on hosted Topic <strong>in</strong> three & Speakers: Sou<strong>the</strong>rn California locations with a simulcast between venues. At<br />

<strong>the</strong> Genentech/ Roche facility <strong>in</strong> Oceanside, Lucy Cabral will <strong>in</strong>troduce a risk-based approach to<br />

manag<strong>in</strong>g Presentation suppliers Overview: and contract manufacturers <strong>in</strong>clud<strong>in</strong>g management oversight levels at contractor<br />

sites dur<strong>in</strong>g <strong>the</strong> supplier/contractor life cycle. At <strong>the</strong> Amgen conference center <strong>in</strong> Thousand<br />

Oaks, This chapter Kev<strong>in</strong> Siver event will will present provide on <strong>in</strong>sight behalf to of <strong>the</strong> Mart<strong>in</strong> current VanTrieste issues <strong>the</strong> on pharmaceutical <strong>the</strong> need for action <strong>in</strong>dustry <strong>in</strong> fac<strong>in</strong>g is fac<strong>in</strong>g <strong>the</strong> <strong>in</strong><br />

crim<strong>in</strong>al secur<strong>in</strong>g activities its supply <strong>in</strong> cha<strong>in</strong> <strong>the</strong> supply and <strong>in</strong>forms cha<strong>in</strong> by you use about of best <strong>the</strong> practices, current and technology, future challenges. collaboration Steven and Wolfgang management<br />

from FDA <strong>in</strong>volvement. will open <strong>the</strong> session At <strong>the</strong> Irv<strong>in</strong>e/Airport from Wash<strong>in</strong>gton Hilton DC Hotel by <strong>in</strong> shar<strong>in</strong>g Orange FDA’s County, latest Gerard th<strong>in</strong>k<strong>in</strong>g Pearce on this will subject. provide<br />

an <strong>in</strong>troduction to Rx-360 and present <strong>the</strong> scope and current accomplishments of <strong>the</strong>ir audit<br />

program The event pilot. will be hosted <strong>in</strong> three Sou<strong>the</strong>rn California locations with a simulcast between venues. At<br />

<strong>the</strong> Genentech/ Roche facility <strong>in</strong> Oceanside, Lucy Cabral will <strong>in</strong>troduce a risk-based approach to<br />

Steven manag<strong>in</strong>g Wolfgang, suppliers PhD and contract is Act<strong>in</strong>g manufacturers Associate Director <strong>in</strong>clud<strong>in</strong>g for Risk management Science, Intelligence oversight levels and Prioritization<br />

at contrac<strong>in</strong><br />

tor <strong>the</strong> sites CDER dur<strong>in</strong>g Office <strong>the</strong> of supplier/contractor Compliance’s new life Office cycle. of At Drug <strong>the</strong> <strong>Security</strong>, Amgen conference Integrity and center Recalls <strong>in</strong> Thousand (ODSIR).<br />

This Oaks, office Kev<strong>in</strong> was Siver formed will present this year on to behalf address of Mart<strong>in</strong> all drug VanTrieste supply cha<strong>in</strong> on <strong>the</strong> related need issues for action with<strong>in</strong> <strong>in</strong> FDA. fac<strong>in</strong>g In <strong>the</strong> his<br />

crim<strong>in</strong>al 6.5 years activities at FDA, <strong>in</strong> Dr. <strong>the</strong> Wolfgang supply cha<strong>in</strong> has been by use <strong>in</strong>volved of best <strong>in</strong> practices, various activities technology, aimed collaboration at promot<strong>in</strong>g and security management<br />

and <strong>in</strong>tegrity <strong>in</strong>volvement. throughout At <strong>the</strong> <strong>the</strong> drug Irv<strong>in</strong>e/Airport component Hilton and f<strong>in</strong>ished Hotel <strong>in</strong> drug Orange supply County, cha<strong>in</strong>s. Gerard These Pearce activities will pro- <strong>in</strong>vide<br />

clude an writ<strong>in</strong>g <strong>in</strong>troduction guidance to Rx-360 for <strong>in</strong>corporation and present of Physical <strong>the</strong> scope / Chemical and current Identifiers accomplishments <strong>in</strong>to drug products, of <strong>the</strong>ir partici- audit<br />

pat<strong>in</strong>g program <strong>in</strong> pilot. research activities for <strong>the</strong> development of analytical screen<strong>in</strong>g tools, and identify<strong>in</strong>g gaps <strong>in</strong><br />

excipient monographs that are currently be<strong>in</strong>g implemented via <strong>the</strong> USP compendial modernization<br />

<strong>in</strong>itiative. Steven Wolfgang, PhD is Act<strong>in</strong>g Associate Director for Risk Science, Intelligence and Prioritization<br />

Prior <strong>in</strong> <strong>the</strong> to CDER jo<strong>in</strong><strong>in</strong>g Office FDA, of Steve Compliance’s spent 15 years new Office as a technical of Drug <strong>Security</strong>, support chemist Integrity with and <strong>the</strong> Recalls API and (ODSIR). excipient<br />

manufactur<strong>in</strong>g This office was division formed this of a year large to address generic all drug drug manufactur<strong>in</strong>g supply cha<strong>in</strong> firm. related He issues has a with<strong>in</strong> Ph.D. FDA. <strong>in</strong> Inorganic In his<br />

Chemistry 6.5 years at from FDA, <strong>the</strong> Dr. City Wolfgang University has of been New <strong>in</strong>volved York and <strong>in</strong> a various B.A. <strong>in</strong> activities Chemistry aimed from at Queens promot<strong>in</strong>g College security (also<br />

<strong>in</strong> and New <strong>in</strong>tegrity York City). throughout <strong>the</strong> drug component and f<strong>in</strong>ished drug supply cha<strong>in</strong>s. These activities <strong>in</strong>clude<br />

writ<strong>in</strong>g guidance for <strong>in</strong>corporation of Physical / Chemical Identifiers <strong>in</strong>to drug products, participat<strong>in</strong>g<br />

<strong>in</strong> research activities for <strong>the</strong> development of analytical screen<strong>in</strong>g tools, and identify<strong>in</strong>g gaps <strong>in</strong><br />

excipient monographs that are currently be<strong>in</strong>g implemented via <strong>the</strong> USP compendial modernization<br />

<strong>in</strong>itiative.<br />

Prior to jo<strong>in</strong><strong>in</strong>g FDA, Steve spent 15 years as a technical support chemist with <strong>the</strong> API and excipient<br />

manufactur<strong>in</strong>g division of a large generic drug manufactur<strong>in</strong>g firm. He has a Ph.D. <strong>in</strong> Inorganic<br />

Chemistry from <strong>the</strong> City University of New York and a B.A. <strong>in</strong> Chemistry from Queens College (also<br />

<strong>in</strong> New York City).


Kev<strong>in</strong> Siver, PhD is a director of Quality at Amgen Inc. He is responsible for Supplier Quality<br />

Management, Quality Systems and Compliance for Amgen’s External Quality organization. External<br />

Quality provides oversight for Amgen’s contract manufacturers and raw material suppliers. Kev<strong>in</strong> has<br />

been <strong>in</strong>volved with various professional and trade organizations, <strong>in</strong>clud<strong>in</strong>g <strong>the</strong> Parenteral Drug<br />

Association (<strong>PDA</strong>), PhRMA, AAPS and ACS. Kev<strong>in</strong> worked with PhRMA’s Stability Technical<br />

Work<strong>in</strong>g Group to provide <strong>in</strong>dustry feedback to ICH Q3A. Kev<strong>in</strong> has over 25 years <strong>in</strong> <strong>the</strong> pharmaceutical<br />

<strong>in</strong>dustry <strong>in</strong> both R&D and Quality. Prior to jo<strong>in</strong><strong>in</strong>g Amgen, he was with Pfizer as Director, Quality<br />

at <strong>the</strong>ir Kalamazoo Operations. He came to Pfizer through Pharmacia, where he served as <strong>the</strong> Global<br />

Stability Manager and was part of <strong>the</strong>ir 21 CFR Part 11 Program Office. He started his career <strong>in</strong> 1986<br />

with Wyeth-Ayerst after obta<strong>in</strong><strong>in</strong>g his PhD <strong>in</strong> Medic<strong>in</strong>al Chemistry from <strong>the</strong> University of Florida.<br />

Lucy Medeiros Cabral is Head of Global Supplier Quality Management and US Distribution Quality.<br />

Lucy has over seventeen years of management experience at Genentech, Inc. <strong>in</strong> <strong>the</strong> Quality<br />

Assurance, Compliance, and Quality Control groups. She has extensive experience manag<strong>in</strong>g<br />

commercial and cl<strong>in</strong>ical contract manufacturers and material suppliers operat<strong>in</strong>g <strong>in</strong> <strong>the</strong> US, Europe,<br />

and Asia. Lucy holds a Bachelor of Arts <strong>in</strong> Biology and she is an expert <strong>in</strong> audit<strong>in</strong>g raw material<br />

suppliers.<br />

Currently Lucy is <strong>the</strong> Head of Supplier Quality Management (Senior Director), for <strong>the</strong> Roche Pharma<br />

worldwide responsible for <strong>the</strong> management of materials (chemicals and components). The team is<br />

responsible for qualify<strong>in</strong>g and monitor<strong>in</strong>g Roche suppliers worldwide of cl<strong>in</strong>ical and commercial<br />

material for biologics and small molecule products. Lucy is also responsible for Distribution Quality<br />

that oversees all distribution centers and third party contractors located <strong>in</strong> <strong>the</strong> US region.<br />

Gerard Pearce is a quality and supply cha<strong>in</strong> expert with over 20 years experience <strong>in</strong> comb<strong>in</strong><strong>in</strong>g <strong>the</strong><br />

discipl<strong>in</strong>es of quality, technology and supply management. His expertise spans a variety of <strong>in</strong>dustries<br />

and geographies, <strong>in</strong>clud<strong>in</strong>g Asia-Pacific, Western Europe, and North America. For <strong>the</strong> last ten years,<br />

Gerard has focused on def<strong>in</strong><strong>in</strong>g <strong>the</strong> <strong>in</strong>frastructure that provides managed supplier quality programs<br />

for numerous global leaders <strong>in</strong> <strong>the</strong> fields of pharmaceuticals, medical devices, electronics, aerospace,<br />

consumer goods and more. Central to this <strong>in</strong>frastructure is <strong>the</strong> technology required for effectively<br />

runn<strong>in</strong>g a global supplier quality operation by connect<strong>in</strong>g all stakeholders <strong>in</strong> <strong>the</strong> supply cha<strong>in</strong>.<br />

Currently <strong>the</strong> executive vice president and head of operations with SQA, Gerard is a regular <strong>in</strong>dustry<br />

commentator and contributor, and is closely <strong>in</strong>volved <strong>in</strong> shap<strong>in</strong>g and implement<strong>in</strong>g <strong>the</strong> global supplier<br />

quality strategy for SQA’s Fortune 500 clients.


About Rx-360: Rx-360 is a non-profit consortium <strong>in</strong>volv<strong>in</strong>g <strong>in</strong>dustry associations such as <strong>PDA</strong>,<br />

pharmaceutical companies, raw material supplier companies, and audit service provider companies.<br />

This consortium has been established to share market surveillance, develop operat<strong>in</strong>g standards,<br />

create an <strong>in</strong>dependent supplier audit function to improve <strong>the</strong> efficiency, oversight and accountability<br />

of <strong>the</strong> pharmaceutical supply cha<strong>in</strong>, and advance technologies for detection and prevention of<br />

material adulteration. This Dem<strong>in</strong>g-based approach promises <strong>the</strong> benefits of monitor<strong>in</strong>g of quality and<br />

security <strong>in</strong> <strong>the</strong> supply cha<strong>in</strong>, standardization of best practices across <strong>in</strong>dustry, and cost reduction <strong>in</strong><br />

<strong>the</strong> supply cha<strong>in</strong>. Participants are <strong>in</strong>vited to learn more about <strong>the</strong> consortium by visit<strong>in</strong>g www.Rx-<br />

360.org.<br />

All those who wish to attend must register.<br />

Register onl<strong>in</strong>e, on or before Aug. 26, us<strong>in</strong>g <strong>the</strong> l<strong>in</strong>k below:<br />

Click Here<br />

Or visit <strong>PDA</strong> website: www.pda.org/sou<strong>the</strong>rncalifornia<br />

and click “Upcom<strong>in</strong>g Events”<br />

Cancellations: Money is nonrefundable if cancellations are made after Friday, August 26th.<br />

For more <strong>in</strong>formation - contact Bill Nichols at (760) 639-1741 OR John Holmgren at (714)<br />

246-5562.<br />

Registration Fee: $ 35 Member<br />

$ 50 Non - Member<br />

$ 25 Government employee<br />

$ 25 Full-time Student<br />

No Charge for Amgen Employee (Thousand Oaks only)<br />

No Charge for Genentech/Roche Employee (Oceanside only)<br />

All Amgen and Genentech/Roche employees must register.


Amgen<br />

One Amgen Center Drive<br />

Thousand Oaks, CA 91320-1799<br />

(805) 447-1000<br />

Directions to Amgen<br />

Travel<strong>in</strong>g Southbound on 101 Freeway Travel<strong>in</strong>g Northbound on 405 and 101 Freeway<br />

Travel<strong>in</strong>g 101 S (towards Los Angeles)<br />

Exit 47A, Borchard Rd. / Rancho Conejo Blvd.<br />

Turn Left on Borchard Rd / Rancho Conejo Blvd<br />

Cont<strong>in</strong>ue to follow Rancho Conejo Blvd.<br />

Turn Right on Hillcrest Drive<br />

Make a Right <strong>in</strong>to Visitor Build<strong>in</strong>g # 34 Park<strong>in</strong>g Lot<br />

Visitors take shuttle to Conference Center<br />

Take 405 N to 101 N (towards Ventura)<br />

Exit 47A, Rancho Conejo Blvd.<br />

Turn Right on Rancho Conejo Blvd<br />

Turn Right on Hillcrest Drive<br />

Make a Right <strong>in</strong>to Visitor Build<strong>in</strong>g # 34 Park<strong>in</strong>g Lot<br />

Visitors take shuttle to Conference Center<br />

Amgen One Amgen Center Drive, Thousand Oaks


Hilton Hotel Irv<strong>in</strong>e/Orange County Airport<br />

18800 MacArthur Blvd.<br />

Irv<strong>in</strong>e, CA 92612<br />

(949) 833-9999<br />

Directions to <strong>the</strong> Hilton Hotel – Irv<strong>in</strong>e / Orange County Airport<br />

Travel<strong>in</strong>g Southbound on 405 Freeway Travel<strong>in</strong>g Northbound on 405 Freeway<br />

Exit Macarthur<br />

Turn Left on Macarthur<br />

Hotel is on left (corner of Macarthur and Douglas)<br />

Exit Macarthur<br />

Turn Left on Macarthur<br />

Hotel is on left (corner of Macarthur and Douglas)<br />

Hilton Hotel – Irv<strong>in</strong>e / Orange County Airport 18800 MacArthur Road, Irv<strong>in</strong>e


Genentech/Roche Oceanside Facility<br />

1 Antibody Way<br />

Oceanside, CA 92056<br />

(760) 231-2440<br />

Directions to Genentech/Roche<br />

Travel<strong>in</strong>g Southbound on 5 Freeway Travel<strong>in</strong>g Northbound on 5 Freeway<br />

Exit for Oceanside Blvd (exit 52)<br />

Turn Left onto Oceanside Blvd.<br />

Turn Left onto Corporate Centre Drive<br />

Turn Right on Antibody Way<br />

Turn Left (dest<strong>in</strong>ation on <strong>the</strong> right<br />

Exit 51b to merge onto CA-78E towards Escondido<br />

Take El Cam<strong>in</strong>o Real / County Highway S11exit<br />

Turn Left onto El Cam<strong>in</strong>o Real<br />

Turn Right onto Oceanside Blvd.<br />

Turn Left onto Corporate Centre Drive<br />

Turn Right on Antibody Way<br />

Turn Left (dest<strong>in</strong>ation on <strong>the</strong> right)<br />

Genentech/Roche Facility 1 Antibody Way, Oceanside

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!